Article | September 29, 2022

Solid Tumors: Asia Pacific Clinical Trial Landscape

Source: Novotech

According to GLOBOCAN, there were over 8.2 million new cases and over 5 million deaths due to solid cancers in Asia, with the region accounting for half of the new cancer cases and 60% of the world's deaths in 2020.

The selected locations of the Asia Pacific region (which include China, India, South Korea, Japan, Australia, New Zealand, Malaysia, Singapore, Thailand and the Philippines), emerged as a hub to an overwhelming cancer population, accounting for over 50%, 45%, 35% and 65% of the global incidence of lung, colorectal, breast and stomach cancers respectively, in 2020. In this region, breast, lung, colorectal and stomach cancers also showed the highest age-standardized incidence rates (ASIR) of 38, 25, 19 and 16 per 100,000 population respectively, in 2020. Lung, colorectal and stomach cancers were also the three top cancer indications where the ASIR even exceeded or was similar to that of the world incidence.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader